HARROW, INC. — Director's Dealing 2015

Feb 3, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Imprimis Pharmaceuticals, Inc. (IMMY)
CIK: 0001360214
Period of Report: 2015-02-01

Reporting Person: BOLL ANDREW R. (Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-02-01	Common Stock	A	157500	—	Acquired	157500	Direct
2015-02-01	Common Stock	A	30000	—	Acquired	187500	Direct

Footnotes

F1: Represents performance-based restricted stock units ("PSUs") granted under the Issuer's 2007 Stock Incentive and Awards Plan (the "Plan"). Each PSU represents a contingent right to receive one share of common stock of the Issuer upon the vesting and settlement of the PSU. The PSUs settle in full on the third anniversary of the grant date if certain stock-price based performance targets have been satisfied during the term of the PSUs.

F2: Represents restricted stock units ("RSUs") granted under the Plan. Each RSU represents a contingent right to receive one share of common stock of the Issuer upon the vesting and settlement of the RSU. The RSUs vest and settle in full on the third anniversary of the date of grant.